Home/Filings/SCHEDULE 13G/0001641172-25-005014
SCHEDULE 13G//SEC Filing

OS Therapies Inc SCHEDULE 13G

Accession 0001641172-25-005014

CIK 0001100397operating

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 2:51 PM ET

Size

8.4 KB

Accession

0001641172-25-005014

Issuer

Ayala Pharmaceuticals, Inc.

CIK 0001100397

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001100397

Filing Metadata

Form type
SCHEDULE 13G
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 2:51 PM ET
Size
8.4 KB